Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study

Caroline S Fox1, Ramachandran S Vasan, Helen Parise

  • 1National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass 01702-5827, USA.

Circulation
|March 26, 2003
PubMed

Insights

Mitral annular calcification (MAC) is a significant indicator of increased cardiovascular disease (CVD) risk. This study found that MAC independently predicts higher risks of CVD events and death, highlighting its importance in risk assessment.

Area of Science:

  • Cardiology
  • Echocardiography
  • Public Health

Background:

  • Mitral annular calcification (MAC) is linked to stroke and cardiovascular disease (CVD) in prior studies.
  • Limited prospective data exist on MAC's association with CVD morbidity and mortality.

Purpose of the Study:

  • To prospectively examine the association between MAC and CVD outcomes.
  • To assess MAC's relation to CVD incidence, CVD death, and all-cause death over 16 years.

Main Methods:

  • Utilized M-mode echocardiography to assess MAC in Framingham Heart Study participants.
  • Employed Cox proportional hazards models for risk estimation.
  • Followed 1197 subjects for 16 years, analyzing 307 CVD events and 621 deaths.

Main Results:

  • 14% of subjects had MAC.
  • MAC was independently associated with increased risk of incident CVD (HR 1.5), CVD death (HR 1.6), and all-cause death (HR 1.3).
  • Each 1-mm increase in MAC correlated with a ~10% rise in CVD and all-cause mortality risk.

Conclusions:

  • Cardiac calcification, specifically MAC, serves as an independent marker of elevated CVD risk.
  • Findings emphasize the clinical significance of MAC in predicting adverse cardiovascular outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...